Article from Dec 18 last year. For those that haven’t read already, it does detail the most recent deal etc. https://smallcaps.com.au/suda-signs-licensing-deal-mitsubishi-tanabe-pharma-asian-sales-zolpimist/
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game